Latest filing published 19 May 2008 for FIRST HORIZON PHARMACEUTICAL CORP, €23k.
No signal scores available.
All filings by Leslie Zacks on record concern First Horizon Pharmaceutical Corp. We count 13 filings; the first trade dates from 24 January 2006 and the latest from 19 May 2008.
Every open-market trade on record is a sale: 9 sales worth €452k. Outside the open market, there are 4 share grants. So far in 2008, the count stands at no purchases and 3 sales.
The latest filing, published on 19 May 2008, reports an open-market sale of €23k in First Horizon Pharmaceutical Corp. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
13 of 13 declarations